Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | VIM |
| Upstream (Parents) |
|---|
| (<<) AKT3 → VIM |
| (<<) CDH11 → VIM |
| (<<) EFEMP1 → VIM |
| (<<) PTRF → VIM |
| (<<) SULF1 → VIM |
| (<<) THY1 → VIM |
| Downstream (Children) |
|---|
| VIM → ACTA2 (>>) |
| VIM → ACTN1 (>>) |
| VIM → ANKRD57 (>>) |
| VIM → ARHGEF2 (>>) |
| VIM → BCL2A1 (>>) |
| VIM → CD83 (>>) |
| VIM → CDC42EP2 (>>) |
| VIM → CEP170 (>>) |
| VIM → CHST11 (>>) |
| VIM → CHST3 (>>) |
| VIM → COL13A1 (>>) |
| VIM → CREB3L1 (>>) |
| VIM → CRYAB (>>) |
| VIM → CTGF (>>) |
| VIM → CTPS (>>) |
| VIM → CYP1B1 (>>) |
| VIM → CYR61 (>>) |
| VIM → DAB2 (>>) |
| VIM → EDNRA (>>) |
| VIM → EFEMP2 (>>) |
| VIM → EMP1 (>>) |
| VIM → FZD1 (>>) |
| VIM → FZD2 (>>) |
| VIM → FZD5 (>>) |
| VIM → GPNMB (>>) |
| VIM → HS2ST1 (>>) |
| VIM → JAK2 (>>) |
| VIM → KCTD12 (>>) |
| VIM → MMP14 (>>) |
| VIM → MMP19 (>>) |
| VIM → MMP2 (>>) |
| VIM → MMP9 (>>) |
| VIM → MYL9 (>>) |
| VIM → NFKB1 (>>) |
| VIM → NRN1 (>>) |
| VIM → ORM1 (>>) |
| VIM → PDGFB (>>) |
| VIM → PIK3CG (>>) |
| VIM → PLAT (>>) |
| VIM → PLAU (>>) |
| VIM → PPP3CB (>>) |
| VIM → PRKCDBP (>>) |
| VIM → PTPRE (>>) |
| VIM → RAB5C (>>) |
| VIM → STX12 (>>) |
| VIM → TIMP1 (>>) |
| VIM → TIMP2 (>>) |
| VIM → TIMP3 (>>) |
| VIM → TPM4 (>>) |
| VIM → TUBA1A (>>) |
| VIM → VAV1 (>>) |
| VIM → VEGFC (>>) |
| VIM → YWHAH (>>) |
| VIM → ZNF365 (>>) |
